Cargando…
Anti-Müllerian hormone as a predictor of polycystic ovary syndrome treated with clomiphene citrate
OBJECTIVE: This study aimed to determine the threshold of anti-Müllerian hormone (AMH) as predictor of follicular growth failure in polycystic ovary syndrome (PCOS) patients treated with clomiphene citrate (CC). METHODS: Fifty female subjects with PCOS were recruited and divided into two groups base...
Autores principales: | Hestiantoro, Andon, Negoro, Yuwono Sri, Afrita, Yohana, Wiweko, Budi, Sumapradja, Kanadi, Natadisastra, Muharam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Reproductive Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234282/ https://www.ncbi.nlm.nih.gov/pubmed/28090459 http://dx.doi.org/10.5653/cerm.2016.43.4.207 |
Ejemplares similares
-
Chronological age vs biological age: an age-related normogram for antral follicle count, FSH and anti-Mullerian hormone
por: Wiweko, Budi, et al.
Publicado: (2013) -
Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients
por: Wiweko, Budi, et al.
Publicado: (2014) -
Correlation of anti-Müllerian hormone levels with metabolic syndrome events in polycystic ovary syndrome: A cross-sectional study
por: Wiweko, Budi, et al.
Publicado: (2020) -
Body fat percentage is a better marker than body mass index for determining inflammation status in polycystic ovary syndrome
por: Hestiantoro, Andon, et al.
Publicado: (2018) -
The correlation between serum AMH and HOMA-IR among PCOS phenotypes
por: Wiweko, Budi, et al.
Publicado: (2018)